HEART failure with preserved ejection fraction (HFpEF) is present in 74% of patients with severe isolated secondary tricuspid ...

For patients with symptomatic and severe tricuspid regurgitation (TR), tricuspid transcatheter edge-to-edge repair (T-TEER) yields significant improvements in primary end points, according to a study ...

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement ...

Dear Dr. Roach: I have venous insufficiency and have a laser procedure by a vein specialist coming up in a couple of weeks. I don’t know much about the procedure and wondered if you can expound ...

About The Study: In this cohort study, the Kansas City Cardiomyopathy Questionnaire (KCCQ) had strong psychometric properties in patients with severe tricuspid regurgitation, including reliability, ...

Unlimited access to all stories from nashuatelegraph.com on your computer, tablet or smart phone. Access nashuatelegraph.com, view our digital edition or use our Full ...

DEAR DR. ROACH: I have venous insufficiency and have a laser procedure by a vein specialist coming up in a couple of weeks. I don’t know much about the procedure and wondered if you can expound on it.

DEAR DR. ROACH: I have venous insufficiency and have a laser procedure by a vein specialist coming up in a couple of weeks. I don’t know much about the procedure and wondered if you can expound ...

TRISCEND II is a randomized controlled pivotal trial designed to study the groundbreaking EVOQUE transcatheter tricuspid valve replacement (TTVR) system with optimal medical therapy (OMT) compared to ...

Highlighted text has been updated as of October 31, 2024. The MATTERHORN trial showed that M-TEER is noninferior to surgical mitral valve repair regarding clinical efficacy and has a better safety ...